©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: GB Sciences
GB Sciences Pursues FDA-Registered, First-in-Human Trial of Cannabis-based Therapy for Parkinson’s Disease
LAS VEGAS --. GB Sciences, Inc. (OTCQB: GBLX) is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather...
GB Sciences Pursues FDA-Registered, First-in-Human Trial of Cannabis-based Therapy for Parkinson’s Disease
LAS VEGAS, April 10, 2018/PR Newswire/--. GB Sciences, Inc. (OTCQB: GBLX) is planning to file an Exploratory IND and perform a Phase 0 Clinical...
GB Sciences Signs Letter of Intent to Acquire NevadaPURE’s Las Vegas Operations
LAS VEGAS -- GB Sciences, Inc. (OTCQB: GBLX) is extremely pleased to announce it has signed a letter of intent to purchase 100% of...
GB Sciences, Inc. Enters A New Market by Signing a Contract Farming Agreement for...
LAS VEGAS, February 27, 2018 - GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce a new agreement with the Colorado Hemp Project to develop...
GB Sciences Louisiana LLC. Will Operate One of Only Two Licenses Granted by the...
LAS VEGAS, February 14, 2018 - GB Sciences, Inc. (OTCQB: GBLX) and its wholly-owned subsidiary GB Sciences Louisiana, LLC (GBSL) are pleased to announce...
GB Sciences Files a Nonprovisional Patent Application for Cannabis-Based Anti-Inflammatory Therapies Including Arthritis, Asthma,...
LAS VEGAS, February 5, 2018/PR Newswire/--GB Sciences, Inc. (OTCQB: GBLX) has filed a nonprovisional patent application to protect its cannabinoid-containing complex mixtures for the...
The Potential of Medical Cannabis: Alzheimer’s Disease
Ask yourself if the following sounds familiar.
You start to notice it happening more often. What was the name of that movie we saw last...
GB Sciences Is Maximizing the Production of Critical Medical Components
Las Vegas, December 8, 2018 /PR Newswire – GB Sciences, Inc. (OTCQB: GBLX) currently markets both medical and adult use cannabis products in Nevada...
Three Complementary Operating Units Produce an Important Genetic Strain
LAS VEGAS, December 13, 2017/PR Newswire/ -- GB Sciences, Inc. (OTCQB: GBLX) is proud to announce its development of a cannabis strain that has...
GB Sciences Exceeds Its Gross Revenue Projections for October, Doubles the Industry Average Yield...
LAS VEGAS, November 15, 2017/PR Newswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces that it has exceeded the October gross revenue projection of $500K...